Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
Background Hyperprolactinaemia is a troublesome side-effect of treatment with antipsychotics. Aims This double-blind, placebo-controlled study aimed at examining the effect of adjunctive treatment wit...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2015-10-01
|
Series: | BJPsych Open |
Online Access: | https://www.cambridge.org/core/product/identifier/S2056472400001058/type/journal_article |